SCHEDULE 13G: FMR LLC and Abigail P. Johnson Disclose 6.3% Stake in Kestra Medical Technologies Inc.
Beneficial Ownership Report
FMR LLC and its affiliates, along with Abigail P. Johnson, have reported a combined beneficial ownership of 6.3% of Kestra Medical Technologies Inc.'s common stock as of March 31, 2025.
Summary
- FMR LLC and Abigail P. Johnson have filed a Schedule 13G, indicating beneficial ownership of Kestra Medical Technologies Inc. common stock.
- As of March 31, 2025, the aggregate amount beneficially owned by FMR LLC and Abigail P. Johnson is 3,117,044 shares.
- This represents 6.3% of the total outstanding common stock of Kestra Medical Technologies Inc.
- FMR LLC holds sole voting and sole dispositive power over these shares.
- The filing states that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
- Abigail P. Johnson is identified as a Director, Chairman, and CEO of FMR LLC, with the Johnson family having significant voting power in FMR LLC.
Sentiment
Score: 7
Explanation: The document is a factual disclosure of a significant ownership stake by a reputable institutional investor, which is generally a neutral to positive signal for the company, indicating institutional interest without implying control intent.
Positives
- Increased institutional ownership by a major financial firm like FMR LLC can signal confidence in the company's long-term prospects.
- The filing indicates a passive investment, suggesting FMR LLC is not seeking to influence control, which can be viewed positively by current management.
Future Outlook
NA
Management Comments
- The filing includes a certification that the securities were acquired and are held in the ordinary course of business and not for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
This filing indicates a significant passive investment by a major asset manager in the medical technology sector, suggesting potential long-term interest in companies within this industry.
Stakeholder Impact
- Shareholders: Increased institutional ownership may be viewed positively, potentially enhancing liquidity and investor confidence.
- Management: The passive nature of the investment suggests no immediate threat to current management or strategic direction.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2025-03-31 | Date of event which required the filing of this statement (ownership threshold crossed). |
| 2025-05-09 | Date of filing/signature of the Schedule 13G. |
Keywords
Kestra Medical Technologies Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, SEC Filing, Medical Technology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.